Patents by Inventor William Ying

William Ying has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11169756
    Abstract: A method for capturing and outputting digital content is herein disclosed and enabled, the output system includes an information apparatus, a server, and a client device. The information apparatus includes at least a digital camera and a wireless communication module (e.g., IEEE 802.11 or Bluetooth). The server is accessible by the client device over a network. The information apparatus, using the digital camera, captures digital content and transmits, over the Internet and using the wireless communication module, the digital content to the server for storage. The server generates output data from at least part of the digital content stored at the server, and provides the generated output data from the server to the client device that has security or authentication information for accessing the server. The client device outputs or plays at least part of the digital content at an output device associated with the client device.
    Type: Grant
    Filed: May 3, 2019
    Date of Patent: November 9, 2021
    Assignee: FlexiJet Technologies, Inc.
    Inventors: William Ho Chang, Christina Ying Liu
  • Publication number: 20210283251
    Abstract: This provides pharmaceutical compositions that comprise (i) an anti-LAG-3 antibody or antigen binding fragment thereof or (ii) an anti-LAG-3 antibody or antigen binding fragment thereof and an anti-PD-1 antibody, anti-PD-L1 antibody, or antigen binding fragment thereof. Also provided are pharmaceutical compositions that comprise a buffering agent, stabilizing or bulking agent, and a surfactant. The disclosure also provides a vial, syringe, intravenous bag, or kit that comprises the compositions, and methods for using the compositions.
    Type: Application
    Filed: May 30, 2018
    Publication date: September 16, 2021
    Applicant: Bristol-Myers Squibb Company
    Inventors: Lori S. BURTON, William YING, Nils LONBERG, Sudhir CHAKRAVARTHI, Pedro SMITH
  • Publication number: 20210252140
    Abstract: The present disclosure describes a pharmaceutical composition comprising at least one antibody and at least one mesenchymal stromal cell-derived protein. Disclosed herein is also the use of said pharmaceutical composition for treating immunological diseases, for example alloimmune and autoimmune diseases. Further disclosed herein is the use of the pharmaceutical composition for immunomodulation.
    Type: Application
    Filed: August 18, 2017
    Publication date: August 19, 2021
    Inventors: Xiubo Fan, William Ying Khee Hwang, Hsiu Ling Low, Julian Thumboo, Chin Teck Ng
  • Publication number: 20190359941
    Abstract: The present invention relates to substituted azole derivatives in combination with cytokines in the ex vivo expansion of CD34+ hematopoietic stem and progenitor cells (HSPC) in a biological sample, more particularly the expansion of these cells obtained from non-enriched, i.e., the mononuclear fraction of the biological sample. The present invention further describes the transplantation regimen of the expanded hematopoietic graft developed through xenotransplantation studies. In a preferred embodiment, the combination comprising the azole based compounds and cytokines selected from SCF, TPO, FLT-3L and IGFBP-2 and results in the expansion of expansion of CD45+CD34+CD38?CD45RA?CD90+ hematopoietic stem cells and/or CD45+CD34+CD38?CD45RA?CD90+CD49f+ hematopoietic stem cells and/or CD45+CD34+CD38?CD45RA? hematopoietic progenitor cells from the mononucleated cells isolated from umbilical cord blood.
    Type: Application
    Filed: August 18, 2017
    Publication date: November 28, 2019
    Applicants: National University of Singapore, Singapore Health Services Pte Ltd
    Inventors: Sudipto BARI, Christina Li Lin CHAI, Gigi Ngar Chee CHIU, William Ying Khee HWANG, Joo Leng LOW, Qixing ZHONG
  • Publication number: 20190262424
    Abstract: The present disclosure describes a pharmaceutical composition comprising at least one antibody and at least one mesenchymal stromal cell-derived protein. Disclosed herein is also the use of said pharmaceutical composition for treating immunological diseases, for example alloimmune and autoimmune diseases. Further disclosed herein is the use of the pharmaceutical composition for immunomodulation.
    Type: Application
    Filed: February 22, 2019
    Publication date: August 29, 2019
    Inventors: Xiubo Fan, William Ying Khee Hwang, Hsiu Ling Low, Julian Thumboo, Chin Teck Ng
  • Patent number: 8338606
    Abstract: The present disclosure generally relates to crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide. The present disclosure also generally relates to a pharmaceutical composition comprising one or more of the crystalline forms, as well of methods of using the crystalline forms in the treatment of Hepatitis C virus (HCV) and methods for obtaining such crystalline forms.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: December 25, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Robert Kevin Perrone, Anne I. Song, Chenchi Wang, William Ying
  • Publication number: 20120230949
    Abstract: The present disclosure generally relates to crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide. The present disclosure also generally relates to a pharmaceutical composition comprising one or more of the crystalline forms, as well of methods of using the crystalline forms in the treatment of Hepatitis C virus (HCV) and methods for obtaining such crystalline forms.
    Type: Application
    Filed: May 16, 2012
    Publication date: September 13, 2012
    Inventors: Robert Kevin Perrone, Anne I. Song, Chenchi Wang, William Ying
  • Patent number: 8202996
    Abstract: The present disclosure generally relates to crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide. The present disclosure also generally relates to a pharmaceutical composition comprising one or more of the crystalline forms, as well of methods of using the crystalline forms in the treatment of Hepatitis C virus (HCV) and methods for obtaining such crystalline forms.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: June 19, 2012
    Assignee: Bristol-Myers Squibb Company
    Inventors: Robert Kevin Perrone, Anne I. Song, Chenchi Wang, William Ying
  • Publication number: 20090202476
    Abstract: The present disclosure generally relates to crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide. The present disclosure also generally relates to a pharmaceutical composition comprising one or more of the crystalline forms, as well of methods of using the crystalline forms in the treatment of Hepatitis C virus (HCV) and methods for obtaining such crystalline forms.
    Type: Application
    Filed: December 8, 2008
    Publication date: August 13, 2009
    Inventors: Robert Kevin Perrone, Anne I. Song, Chenchi Wang, William Ying